• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过电荷修饰预防生物人工心脏瓣膜组织钙化:甲醛结合鱼精蛋白的作用

Prevention of bioprosthetic heart valve tissue calcification by charge modification: effects of protamine binding by formaldehyde.

作者信息

Golomb G, Ezra V

机构信息

School of Pharmacy, Hebrew University of Jerusalem, Israel.

出版信息

J Biomed Mater Res. 1991 Jan;25(1):85-98. doi: 10.1002/jbm.820250107.

DOI:10.1002/jbm.820250107
PMID:1902234
Abstract

Calcification is the principal cause of the clinical failure of bioprosthetic heart valves (BHV). Calcification occurs through an interaction of host and implant factors, mainly younger age and glutaraldehyde pretreatment, respectively. The hypothesis of this work was that an impaired balance between positively and negatively charged amino acids, due to the reaction with Lys and Hyl tissue-collagen residues, expose affinity sites to Ca++. We further hypothesized that regardless of the cause(s) of BHV calcification, positive charge modification of the tissues will prevent their propensity to calcify. Modification of BHV tissue was obtained by covalently binding protamine sulfate, a polybasic peptide, via formaldehyde and subsequent glutaraldehyde tissue crosslinking. Protamine-bound tissue exhibited stability properties (shrinkage temperature and resistance to collagenase digestion) similar to BHV tissue. Protamine-treated tissue was less permeable to Ca++, and reduced staining was observed with positively charged dyes, indicating the presence of positively charged functional groups in the modified tissue. Significant prevention of calcification was exhibited by the p-bound tissue in comparison to BHV tissue, 30.9 and 109 micrograms/mg calcium, respectively, after 30 days of subdermal implants in rats. The modification procedure resulted in stable, covalent links of approximately 10% w/w protamine with undiminished anticalcification properties, even after 1 year storage. The results support our hypotheses, and orthotopical heart valve replacements are required in order to completely evaluate the treatment efficacy and biocompatibility.

摘要

钙化是生物人工心脏瓣膜(BHV)临床失效的主要原因。钙化通过宿主和植入物因素的相互作用发生,主要分别是年龄较小和戊二醛预处理。这项工作的假设是,由于与赖氨酸(Lys)和羟赖氨酸(Hyl)组织胶原蛋白残基反应,正负电荷氨基酸之间的平衡受损,从而使亲和位点暴露于钙离子(Ca++)。我们进一步假设,无论BHV钙化的原因是什么,组织的正电荷修饰将阻止其钙化倾向。通过经由甲醛共价结合硫酸鱼精蛋白(一种多碱性肽)并随后进行戊二醛组织交联来实现BHV组织的修饰。结合鱼精蛋白的组织表现出与BHV组织相似的稳定性特性(收缩温度和对胶原酶消化的抗性)。经鱼精蛋白处理的组织对Ca++的渗透性较低,并且用带正电荷的染料观察到染色减少,表明修饰后的组织中存在带正电荷的官能团。与BHV组织相比,结合鱼精蛋白的组织在大鼠皮下植入30天后分别显示出显著的钙化预防效果,钙含量分别为30.9和109微克/毫克。即使经过1年的储存,修饰过程也导致约10%(重量/重量)的鱼精蛋白形成稳定的共价连接,且抗钙化性能未降低。结果支持了我们的假设,并且需要进行原位心脏瓣膜置换以全面评估治疗效果和生物相容性。

相似文献

1
Prevention of bioprosthetic heart valve tissue calcification by charge modification: effects of protamine binding by formaldehyde.通过电荷修饰预防生物人工心脏瓣膜组织钙化:甲醛结合鱼精蛋白的作用
J Biomed Mater Res. 1991 Jan;25(1):85-98. doi: 10.1002/jbm.820250107.
2
Covalent binding of protamine by glutaraldehyde to bioprosthetic tissue: characterization and anticalcification effect.通过戊二醛使鱼精蛋白与生物假体组织共价结合:表征及抗钙化作用
Biomater Artif Cells Immobilization Biotechnol. 1992;20(1):31-41. doi: 10.3109/10731199209117856.
3
Mechanical properties and histology of charge modified bioprosthetic tissue resistant to calcification.抗钙化电荷修饰生物假体组织的力学性能和组织学
Biomaterials. 1992;13(6):353-6. doi: 10.1016/0142-9612(92)90039-q.
4
Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde cross-linked porcine aortic valves.2-氨基油酸暴露条件对戊二醛交联猪主动脉瓣钙化抑制作用的影响
J Biomed Mater Res. 1994 Dec;28(12):1485-95. doi: 10.1002/jbm.820281214.
5
Calcification of tissue heart valve substitutes: progress toward understanding and prevention.组织心脏瓣膜替代品的钙化:在理解和预防方面的进展
Ann Thorac Surg. 2005 Mar;79(3):1072-80. doi: 10.1016/j.athoracsur.2004.06.033.
6
Diamine-extended glutaraldehyde- and carbodiimide crosslinks act synergistically in mitigating bioprosthetic aortic wall calcification.二胺扩链的戊二醛和碳二亚胺交联在减轻生物人工主动脉壁钙化方面具有协同作用。
J Heart Valve Dis. 2005 Jul;14(4):538-45.
7
A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification.一种使用亚硫酸氢钠修饰牛心包的新型抗钙化策略。
J Heart Valve Dis. 2009 Mar;18(2):180-5; discussion 186.
8
Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies.酒精预处理预防戊二醛固定生物人工心脏瓣膜钙化:进一步的机制研究
J Heart Valve Dis. 2000 Jul;9(4):561-6.
9
Ethanol inhibition of porcine bioprosthetic heart valve cusp calcification is enhanced by reduction with sodium borohydride.用硼氢化钠还原可增强乙醇对猪生物心脏瓣膜尖钙化的抑制作用。
J Heart Valve Dis. 2004 May;13(3):487-93.
10
Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential.用长链醇溶液处理生物人工心脏瓣膜组织以降低钙化潜能。
J Biomed Mater Res A. 2004 Apr 1;69(1):140-4. doi: 10.1002/jbm.a.20129.

引用本文的文献

1
The design and development of a stented tissue mitral and aortic heart valve replacement for human implantation.一种用于人体植入的带支架组织二尖瓣和主动脉心脏瓣膜置换物的设计与开发。
Cardiovasc J Afr. 2012 Apr;23(3):126-30. doi: 10.5830/CVJ-21.059.
2
A review of the biocompatibility of implantable devices: current challenges to overcome foreign body response.植入式设备的生物相容性综述:克服异物反应的当前挑战
J Diabetes Sci Technol. 2008 Nov;2(6):1003-15. doi: 10.1177/193229680800200610.
3
Assessing anticalcification treatments in bioprosthetic tissue by using the New Zealand rabbit intramuscular model.
通过使用新西兰兔肌肉内模型评估生物假体组织中的抗钙化治疗。
Comp Med. 2009 Jun;59(3):266-71.
4
Polyphenol-stabilized tubular elastin scaffolds for tissue engineered vascular grafts.用于组织工程血管移植物的多酚稳定管状弹性蛋白支架
Tissue Eng Part A. 2009 Oct;15(10):2837-51. doi: 10.1089/ten.TEA.2008.0394.
5
A new route of drug administration: intrauterine delivery of insulin and calcitonin.
Pharm Res. 1993 Jun;10(6):828-33. doi: 10.1023/a:1018948924992.
6
Bisacylphosphonates inhibit hydroxyapatite formation and dissolution in vitro and dystrophic calcification in vivo.
Pharm Res. 1992 Jan;9(1):143-8. doi: 10.1023/a:1018956516640.